What does Dr. Kristof DEBEN, otorhinolaryngologie do?

Dr. Kristof DEBEN, otorhinolaryngologie is a specialist medical practice in Alken. Private Limited, started on 7 May 2007, 1 establishment.

What is the address of Dr. Kristof DEBEN, otorhinolaryngologie?

The registered office of Dr. Kristof DEBEN, otorhinolaryngologie is located at Motstraat 52, 3570 Alken.

Is Dr. Kristof DEBEN, otorhinolaryngologie still active?

Yes. According to the CBE (29 September 2026) Dr. Kristof DEBEN, otorhinolaryngologie is active, legal situation “Normale toestand”, started on 7 May 2007.

Is Dr. Kristof DEBEN, otorhinolaryngologie registered on Peppol?

Yes, Dr. Kristof DEBEN, otorhinolaryngologie is registered on the Peppol network with ID 0208:0889241362.

What is the enterprise number of Dr. Kristof DEBEN, otorhinolaryngologie?

The enterprise number of Dr. Kristof DEBEN, otorhinolaryngologie is BE0889241362.

When was Dr. Kristof DEBEN, otorhinolaryngologie founded?

Dr. Kristof DEBEN, otorhinolaryngologie was founded on 7 May 2007.

Who are the directors of Dr. Kristof DEBEN, otorhinolaryngologie?

According to the 2025 annual accounts, the directors of Dr. Kristof DEBEN, otorhinolaryngologie are: Kristof Deben.

Is Dr. Kristof DEBEN, otorhinolaryngologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 May 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Kristof DEBEN, otorhinolaryngologie make in 2025?

Dr. Kristof DEBEN, otorhinolaryngologie posted a profit after taxes of € 147,423 in financial year 2025.

What is the revenue of Dr. Kristof DEBEN, otorhinolaryngologie?

As a small company, Dr. Kristof DEBEN, otorhinolaryngologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 284,188.

Dr. Kristof DEBEN, otorhinolaryngologie (Private Limited)

Dossier Dr. Kristof DEBEN, otorhinolaryngologie, printed on 29 September 2026 from databakkes.be/en/0889241362/dr-kristof-deben-otorhinolaryngologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Kristof DEBEN, otorhinolaryngologie from Alken, company number BE0889241362, closed financial year 2025 with a result of € 147,423 after tax. For that financial year Dr. Kristof DEBEN, otorhinolaryngologie recorded a gross margin of € 284,188 and equity of € 665,798. Compared with financial year 2024, the result moved from € 129,809 to € 147,423. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Healthy

€ 665,798

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 147,423

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 124,208

▼ 40% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 182,433 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 66,360

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 179,535

▼ 22% vs 2024

€ 53,303 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 18,897

▲ 17% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,467

▲ 68% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 218,002 Gross margin 2022: € 218,002 First fiscal year in the series	€ 246,908 Gross margin 2023: € 246,908 ▲ 13% vs 2022 (€ 218,002) Favourable step	€ 262,196 Gross margin 2024: € 262,196 ▲ 6% vs 2023 (€ 246,908) Favourable step	€ 284,188 Gross margin 2025: € 284,188 ▲ 8% vs 2024 (€ 262,196) Favourable step	▲ 8%
Profit after taxes	€ 97,668 Profit after taxes 2022: € 97,668 First fiscal year in the series	€ 124,143 Profit after taxes 2023: € 124,143 ▲ 27% vs 2022 (€ 97,668) Favourable step	€ 129,809 Profit after taxes 2024: € 129,809 ▲ 5% vs 2023 (€ 124,143) Favourable step	€ 147,423 Profit after taxes 2025: € 147,423 ▲ 14% vs 2024 (€ 129,809) Favourable step	▲ 14%
Equity	€ 535,303 Equity 2022: € 535,303 First fiscal year in the series	€ 630,329 Equity 2023: € 630,329 ▲ 18% vs 2022 (€ 535,303) Favourable step	€ 700,809 Equity 2024: € 700,809 ▲ 11% vs 2023 (€ 630,329) Favourable step	€ 665,798 Equity 2025: € 665,798 ▼ 5% vs 2024 (€ 700,809) Unfavourable step	▼ 5%
Total debts	€ 319,843 Total debts 2022: € 319,843 First fiscal year in the series	€ 358,138 Total debts 2023: € 358,138 ▲ 12% vs 2022 (€ 319,843) Unfavourable step	€ 295,889 Total debts 2024: € 295,889 ▼ 17% vs 2023 (€ 358,138) Favourable step	€ 245,855 Total debts 2025: € 245,855 ▼ 17% vs 2024 (€ 295,889) Favourable step	▼ 17%
Cash	€ 214,996 Cash 2022: € 214,996 First fiscal year in the series	€ 206,370 Cash 2023: € 206,370 ▼ 4% vs 2022 (€ 214,996) Unfavourable step	€ 206,042 Cash 2024: € 206,042 Unchanged (€ 206,370) Unfavourable step	€ 124,208 Cash 2025: € 124,208 ▼ 40% vs 2024 (€ 206,042) Unfavourable step	▼ 40%
Land & buildings	€ 488,339 Land & buildings 2022: € 488,339 First fiscal year in the series	€ 486,321 Land & buildings 2023: € 486,321 Unchanged (€ 488,339) Unchanged	€ 460,123 Land & buildings 2024: € 460,123 ▼ 5% vs 2023 (€ 486,321) Unchanged	€ 458,018 Land & buildings 2025: € 458,018 Unchanged (€ 460,123) Unchanged
Retained profit	€ 522,903 Retained profit 2022: € 522,903 First fiscal year in the series	€ 617,929 Retained profit 2023: € 617,929 ▲ 18% vs 2022 (€ 522,903) Favourable step	€ 688,409 Retained profit 2024: € 688,409 ▲ 11% vs 2023 (€ 617,929) Favourable step	€ 653,398 Retained profit 2025: € 653,398 ▼ 5% vs 2024 (€ 688,409) Unfavourable step	▼ 5%
Dividend	€ 71,957 Dividend 2022: € 71,957 First fiscal year in the series	€ 29,117 Dividend 2023: € 29,117 ▼ 60% vs 2022 (€ 71,957) Unchanged	€ 59,330 Dividend 2024: € 59,330 ▲ 104% vs 2023 (€ 29,117) Unchanged	€ 182,433 Dividend 2025: € 182,433 ▲ 207% vs 2024 (€ 59,330) Unchanged	▲ 207%
Bank debt	€ 231,671 Bank debt 2022: € 231,671 First fiscal year in the series	€ 278,908 Bank debt 2023: € 278,908 ▲ 20% vs 2022 (€ 231,671) Unfavourable step	€ 230,389 Bank debt 2024: € 230,389 ▼ 17% vs 2023 (€ 278,908) Favourable step	€ 179,535 Bank debt 2025: € 179,535 ▼ 22% vs 2024 (€ 230,389) Favourable step	▼ 22%
Balance sheet total	€ 855,147 Balance sheet total 2022: € 855,147 First fiscal year in the series	€ 988,468 Balance sheet total 2023: € 988,468 ▲ 16% vs 2022 (€ 855,147) Unchanged	€ 996,698 Balance sheet total 2024: € 996,698 ▲ 1% vs 2023 (€ 988,468) Unchanged	€ 911,653 Balance sheet total 2025: € 911,653 ▼ 9% vs 2024 (€ 996,698) Unchanged	▼ 9%

Key figures of Dr. Kristof DEBEN, otorhinolaryngologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Kristof DEBEN, otorhinolaryngologie?

What happened at Dr. Kristof DEBEN, otorhinolaryngologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 147,423 (▲ 14% vs 2024). Source: NBB ↗
May 7, 2007 Start of the company according to the CBE. KBO
May 3, 2007 New establishment in Alken. KBO

In short

From € 97,668 profit in 2022 to € 147,423 profit in 2025.

Paid € 227,457 in corporate taxes since 2022.

Best year ever: 2025, with € 147,423 profit.

Paid out € 342,837 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Kristof DEBEN, otorhinolaryngologie? We notify you, reason included.

Follow Dr. Kristof DEBEN, otorhinolaryngologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Kristof Deben

Dr. Kristof DEBEN, otorhinolaryngologie

Behind Dr. Kristof DEBEN, otorhinolaryngologie is Kristof Deben.

See the full network in the app

Directors

According to the 2025 annual accounts

Kristof Deben

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Motstraat 52

3570 Alken

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0889.241.362
VAT number: BE 0889.241.362
Registered office: Motstraat 52, 3570 Alken
Names & denominations: Dr. Kristof DEBEN, otorhinolaryngologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 May 2007
Peppol: Active · Active since 21 Aug 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗